In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Focused Consolidator: bioMerieux

Executive Summary

As its traditional market in microbiology matures, bioMerieux is tryiing to branch out into broader areas of infectious diseases. But it is confronting a tough environment with lots of competition and rapid consolidation
Advertisement

Related Content

bioMerieux, a Family-Owned French Firm, Finally Goes Public
On the Verge of a Deal for Dade Behring
On the Verge of a Deal for Dade Behring
A Tepid Wedding, Now A Possible Divorce
bioMerieux-Pierre Fabre Lives Up to Its Name
bioMerieux's and Pierre Fabre's Surprise

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV000934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel